Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Azelaprag

🥰Excellent
Catalog No. T14390Cas No. 2049980-18-7
Alias AMG 986

Azelaprag (Example 263.0) is a candidate active molecule (EC50= 0.32 nM) for an apelin receptor agonist. Azelaprag can be used to treat nervous system diseases, cardiovascular diseases.

Azelaprag

Azelaprag

🥰Excellent
Purity: 100%
Catalog No. T14390Alias AMG 986Cas No. 2049980-18-7
Azelaprag (Example 263.0) is a candidate active molecule (EC50= 0.32 nM) for an apelin receptor agonist. Azelaprag can be used to treat nervous system diseases, cardiovascular diseases.
Pack SizePriceAvailabilityQuantity
1 mg$107In Stock
5 mg$263In Stock
10 mg$413In Stock
25 mg$712In Stock
1 mL x 10 mM (in DMSO)$336In Stock
Add to Cart
Add to Quotation
Bulk & Custom
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
View More

Batch Information

Select Batch
Purity:100%
ee:99.66%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Azelaprag (Example 263.0) is a candidate active molecule (EC50= 0.32 nM) for an apelin receptor agonist. Azelaprag can be used to treat nervous system diseases, cardiovascular diseases.
Targets&IC50
RAGE:12.7 ± 7.6 nM (kd), apelin receptor:0.32 nM (EC50)
In vivo
METHODS: To investigate the effect of Azelaprag on cardiac function, Azelaprag (1mg/kg/min) was infused intravenously at an acute time point in a rat model of impaired metabolic function.
RESULTS: Azelaprag increased cardiac reserve during Dobutamine challenge in a metabolically impaired rat model. [1]
SynonymsAMG 986
Chemical Properties
Molecular Weight523.61
FormulaC25H29N7O4S
Cas No.2049980-18-7
SmilesN(S([C@H]([C@H](C)C=1N=CC(C)=CN1)C)(=O)=O)C=2N(C(=NN2)C=3C=C(C)C=NC3)C4=C(OC)C=CC=C4OC
Relative Density.1.35 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (114.59 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9098 mL9.5491 mL19.0982 mL95.4909 mL
5 mM0.3820 mL1.9098 mL3.8196 mL19.0982 mL
10 mM0.1910 mL0.9549 mL1.9098 mL9.5491 mL
20 mM0.0955 mL0.4775 mL0.9549 mL4.7745 mL
50 mM0.0382 mL0.1910 mL0.3820 mL1.9098 mL
100 mM0.0191 mL0.0955 mL0.1910 mL0.9549 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Azelaprag | purchase Azelaprag | Azelaprag cost | order Azelaprag | Azelaprag chemical structure | Azelaprag in vivo | Azelaprag formula | Azelaprag molecular weight